At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 43 enrolled
Drug / intervention
lisdexamfetamine/Behavior Therapy +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Lisdexamfetamine Treatment for Cocaine Dependence
In Brief
A Phase 2 clinical trial evaluating lisdexamfetamine/Behavior Therapy and placebo for Cocaine Dependence. Completed, enrolled 43 participants across 1 site.
Detailed Summary
This protocol is a 2-group double-blind placebo-controlled outpatient study investigating lisdexamfetamine for treatment of cocaine dependence. The investigators plan to enroll 100 subjects in a 14-week trial. The primary objectives will determine changes in cocaine use and secondary objectives will be cocaine craving and impulsivity.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCocaine Dependence
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2009
First PostedAug 2009
Primary CompletionJan 2013
TodayJul 2026
First PostedAug 13, 2009
Enrollment StartJul 1, 2009
Primary CompletionJan 1, 2013
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 16.9 years ago
Interventions
lisdexamfetamine/Behavior Therapydrug
placeboother